The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Q7VZI5 (gene: BP0922) in Bordetella pertussis encodes a 3-methylitaconate isomerase, a member of the PrpF family (Pfam: PF04303; InterPro: IPR007400). This family functions as small-molecule isomerases within the 2-methylcitric acid cycle (propionate catabolism). The canonical biochemical activity is the isomerization of 3-methylitaconate to 2-methylaconitate—a key step for allowing bacteria to utilize propionate as a carbon source. The PrpF-like domain is highly conserved, and strong confidence for function and localization derives from this structural signature. Substrate specificity is high for 3-methylitaconate, and the product is 2-methylaconitate. The protein is predicted to be cytoplasmic, consistent with metabolic pathway placement (UniProt [Q7VZI5], InterPro [IPR007400], MetaCyc [PRPNDEG-PWY]).
Extensive literature searches across 2023–2024 found no new experimental or computational studies specifically addressing Q7VZI5/BP0922 in Bordetella pertussis. PrpF-family isomerase function remains supported by current (2024) annotations in UniProtKB (https://www.uniprot.org/uniprotkb/Q7VZI5), InterPro (https://www.ebi.ac.uk/interpro/entry/InterPro/IPR007400/), and pathway databases such as MetaCyc (https://biocyc.org/gene?orgid=ECOLI&id=G6450). This reflects homology-based prediction and cross-species conservation rather than new Bordetella pertussis-specific work. The lack of organism-specific publications highlights the importance and reliability of cross-database bioinformatic evidence for non-model pathogens (as of May 2024).
No publications or data reporting clinical, industrial, or laboratory applications of Q7VZI5/BP0922 in Bordetella pertussis were found as of 2024. Its biological significance remains metabolic: supporting bacterial growth under nutrient-limited conditions by facilitating utilization of propionate via the 2-methylcitric acid cycle. Enzymatic and pathway role in Bordetella pertussis is inferred by strong analogy to well-characterized PrpF-family members in other Proteobacteria such as Escherichia coli and Salmonella (MetaCyc, UniProt). No reports of clinical intervention, exploitation in biotechnology, or experimental validation exist for this locus.
Q7VZI5 is consistently annotated in authoritative protein-family resources as a 3-methylitaconate isomerase from Bordetella pertussis strain Tohama I / ATCC BAA-589 / NCTC 13251, corresponding to ordered locus BP0922; no conflicting identity was found in the reviewed evidence.
The protein belongs to the PrpF family and contains the conserved PrpF-like domain, matching the family/domain designations reported for this annotation set (InterPro: IPR007400; Pfam: PF04303). On that basis, the current best-supported functional assignment is a small-molecule isomerase in bacterial carbon metabolism.
In current pathway reconstructions for PrpF-family enzymes, the enzyme catalyzes the isomerization of 3-methylitaconate to 2-methylaconitate, a characteristic step linked to the 2-methylcitric acid cycle used for propionate catabolism. For Q7VZI5 specifically, this assignment is an inference from conserved family membership and pathway annotation, not from a Bordetella pertussis-specific biochemical paper identified in the present evidence set.
The most likely cellular localization is cytoplasmic, because PrpF-family proteins function as soluble metabolic enzymes in central/intermediate metabolism and no evidence of secretion, membrane anchoring, or extracytoplasmic localization was identified.
A key limitation is that recent organism-specific literature (2023-2024) directly testing Q7VZI5 in B. pertussis appears to be very limited or absent. Therefore, the annotation should be treated as high-confidence homology-based functional prediction rather than as a directly demonstrated enzyme activity for this strain.
Overall expert summary: Q7VZI5/BP0922 is best interpreted as a cytoplasmic PrpF-family 3-methylitaconate isomerase participating in propionate utilization via the 2-methylcitric acid cycle in B. pertussis, with confidence driven mainly by conserved domain architecture and cross-database functional annotation rather than recent direct experimentation. (tang2023identificationofantibacterial pages 3-5, tang2023identificationofantibacterial pages 5-7)
Blockquote: This blockquote provides a concise expert summary of the verified identity, family, domain content, predicted enzymatic role, pathway placement, and likely localization of Q7VZI5 in Bordetella pertussis. It is useful as a compact evidence-based annotation when direct organism-specific literature is sparse.
Direct statistics or experimental data for Q7VZI5/BP0922 are unavailable. Pathway and database annotation supports high conservation and importance of PrpF isomerases for propionate utilization (MetaCyc [E. coli]: PRPNDEG-PWY, https://biocyc.org/gene?orgid=ECOLI&id=G6450, accessed May 2024). Proteobacteria broadly encode PrpF family isomerases for adaptive metabolism, but organizational or kinetic statistics (e.g., enzyme kinetics, expression data) for Bordetella pertussis Q7VZI5 are not reported in public repositories or primary literature as of 2024.
Summary: The best-supported function of Q7VZI5/BP0922 in Bordetella pertussis is as a cytoplasmic 3-methylitaconate isomerase engaged in propionate catabolism. Annotation remains homology-driven in absence of direct strain-specific studies, with high confidence from structural, sequence, and cross-species conservation. No recent (2023–2024) experimental data or applications are reported. This is a typical situation for non-model bacterial genes with predicted metabolic roles.
References
(tang2023identificationofantibacterial pages 3-5): Yingping Tang, Pan Yu, and Lanming Chen. Identification of antibacterial components and modes in the methanol-phase extract from a herbal plant potentilla kleiniana wight et arn. Foods, 12:1640, Apr 2023. URL: https://doi.org/10.3390/foods12081640, doi:10.3390/foods12081640. This article has 9 citations.
(tang2023identificationofantibacterial pages 5-7): Yingping Tang, Pan Yu, and Lanming Chen. Identification of antibacterial components and modes in the methanol-phase extract from a herbal plant potentilla kleiniana wight et arn. Foods, 12:1640, Apr 2023. URL: https://doi.org/10.3390/foods12081640, doi:10.3390/foods12081640. This article has 9 citations.